CordovaCann (LVRLF) Non-Current Deffered Revenue (2021 - 2024)
CordovaCann (LVRLF) recorded quarterly Non-Current Deffered Revenue of $26356.9 in Q2 2024, down 59.19% quarter-over-quarter from $64582.7 in Q2 2023, and down 59.19% on a YoY basis from $64582.7 in Q3 2023.
CordovaCann (LVRLF) Non-Current Deffered Revenue (2021 - 2024) Analysis & Trends
CordovaCann's Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $26356.9 for Q2 2024.
- In Q2 2024, Non-Current Deffered Revenue fell 59.19% year-over-year to $26356.9; the TTM figure through Jun 2024 stood at $26356.9 (down 59.19% YoY), while the FY2024 annual figure was $26620.7, down 58.93% from the prior year.
- Non-Current Deffered Revenue was $26356.9 for Q2 2024 at CordovaCann, down from $64582.7 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $144865.6 in Q2 2021 to a low of $26356.9 in Q2 2024.
- Historically, Non-Current Deffered Revenue has averaged $85408.1 across 4 years, with a median of $85205.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue dropped 26.95% in 2022, then plunged 59.19% in 2024.
- A 4-year view of Non-Current Deffered Revenue shows it stood at $144865.6 in 2021, then decreased by 26.95% to $105827.2 in 2022, then tumbled by 38.97% to $64582.7 in 2023, then slumped by 59.19% to $26356.9 in 2024.
- The last three Non-Current Deffered Revenue figures came in at $26356.9 (Q2 2024), $64582.7 (Q2 2023), and $105827.2 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 26,356.89 |
| Jun 30, 2023 | 64,582.74 |
| Jun 30, 2022 | 105,827.16 |
| Jun 30, 2021 | 144,865.59 |